| Literature DB >> 29606173 |
Emil P Lesho1, Erik Snesrud2, Melissa Bronstein3, Margaret Pettis4, Ana Ong2, Rosslyn Maybank2, Yoon Kwak2, Anthony Jones2, Kelly Vore4, Patrick McGann2, Mary Hinkle2.
Abstract
Entities:
Mesh:
Year: 2018 PMID: 29606173 PMCID: PMC6088778 DOI: 10.1017/ice.2018.73
Source DB: PubMed Journal: Infect Control Hosp Epidemiol ISSN: 0899-823X Impact factor: 3.254
Potential Impact of an Outbreak Investigation for Surgical Site Infection due to Group A Streptococcus
| Day and Event | Patient / Hospital | Surgeon / No. of Support Staff |
| Day 0, Surgical procedure | Patient A / Hospital X | Surgeon I / 1 Staff |
| Day 5, GAS infection | Patient A / Hospital X | |
| Day 7, Surgical procedure | Patient B / Hospital X | Surgeon II / 9 Staff |
| Day 8, Surgical procedure | Patient B / Hospital Y | Surgeon II / 10 Staff |
| Day 13, GAS infection | Patient B / Hospital Y | |
| Total of 22 Possible Carriers | ||
| Costs | Conventional approach | Real-time sequencing approach |
|
| ||
| Laboratory | $175.00 | $80.00 |
| Infection preventionist labor | 10 RN+hours=$500.00 | $0.00 |
| Employee health labor | 8 RN+hours=$400.00 | $0.00 |
|
| ||
| Lost revenue due to time surgical staff not operating due to specimen collection or on furlough if screened positive and awaiting genotyping and/or decolonization | Potentially $1,000–100,000 depending on number of staff involved and time line | $0.00 |
RN+, registered nurse at 90% effort with Advanced Practitioner or Physician Oversight at 10% effort.